Summary
Biomarkers have shown great potential in molecular classification and targeted treatment of human diseases. Biomarkers are also expected to play an increasingly important role in all phases of drug development as well as regulatory decision making. However, translating biomarker discovery into clinically useful tests in a time- and cost-effective manner remains a significant challenge. Real-time polymerase chain reaction (PCR) technology, in particular TaqMan®-based real-time PCR gene expression assays, provides a simple, robust, and practical tool that has shown great potential in bridging the gaps between biomarker discovery and clinical practice. In this chapter, we will survey the principle of this technology and its wide applications in biomarker discovery and validation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques 1998;24:954–958, 960, 962.
Bonnet G, Tyagi S, Libchaber A, Kramer FR. Thermodynamic basis of the enhanced specificity of structured DNA probes. Proc Natl Acad Sci U S A 1999; 96:6171–6176.
Tyagi S, Kramer FR. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996;14:303–308.
Wittwer CT, Herrmann MG, Moss AA, Rasmussen RP. Continuous fluorescence monitoring of rapid cycle DNA amplification. Biotechniques 1997;22: 130–131, 134–138.
SantaLucia J, Jr. A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci U S A 1998; 95:1460–1465.
Ramaswamy S. Translating cancer genomics into clinical oncology. N Engl J Med 2004;350:1814–1816.
Sorlie T, Wang Y, Xiao C, et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 2006;7:127.
Canales RD, Luo Y, Willey JC, et al. Evaluation of DNA microarray results with quantitative gene expression platforms. Nat Biotechnol 2006;24:1115–1122.
Wang Y, Barbacioru C, Hyland F, et al. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. BMC Genomics 2006;7:59.
Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004;350:1828–1837.
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834–838.
Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6–7.
Chen C, Ridzon DA, Broomer AJ, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:e179.
Dai Z, Barbacioru C, Huang Y, Sadee W. Prediction of anticancer drug potency from expression of genes involved in growth factor signaling. Pharm Res 2006;23:336–349.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Wang, Y. et al. (2008). Real-Time Polymerase Chain Reaction Gene Expression Assays in Biomarker Discovery and Validation. In: Wang, F. (eds) Biomarker Methods in Drug Discovery and Development. Methods in Pharmacology and Toxicology™. Humana Press. https://doi.org/10.1007/978-1-59745-463-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-59745-463-6_4
Publisher Name: Humana Press
Print ISBN: 978-1-934115-23-7
Online ISBN: 978-1-59745-463-6
eBook Packages: Springer Protocols